SFX by Ex Libris Inc.

Title:	Diverse somatic mutation patterns and pathway alterations in human cancers
Source:	Nature [0028-0836] Kan, Z yr:2010

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Lee, W. "The mutation spectrum revealed by paired genome sequences from a lung cancer patient." Nature 465.7297 (2010): 473-477.
description	2.	Brown, Patrick O O. "Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors." Proceedings of the National Academy of Sciences of the United States of America 99.20 (2002): 12963-8.
description	3.	Meng, S. "HER-2 gene amplification can be acquired as breast cancer progresses." Proceedings of the National Academy of Sciences of the United States of America 101.25 (2004): 9393-8.
description	4.	Croce, Carlo M M. "Oncogenes and cancer." New England Journal of Medicine, The 358.5 (2007): 502-11.
description	5.	Asa, Sylvia L L. "the pathogenesis of pituitary tumours." Nature reviews. Cancer 2.11 (2002): 836-849.
description	6.	Visvader, Jane E. "Cells of origin in cancer." Nature 469.7330 (2011): 314-322.
description	7.	Shaulian, E. "AP-1—The Jun proteins: Oncogenes or tumor suppressors in disguise?" Cellular signalling 22.6 (2010): 894-899.
description	8.	Lam, Carson K. "Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization." Nature 465.7297 (2010): 478-482.
description	9.	Cortot, Alexis B. "KRAS mutation status in primary nonsmall cell lung cancer and matched metastases." Cancer 116.11 (2010): 2682-2687.
description	10.	Ito, T. "Identification of a primary target of thalidomide teratogenicity." Science 327.5971 (2010): 1345-1350.
description	11.	Ng, Peggy D. "Targeted capture and massively parallel sequencing of 12 human exomes." Nature 461.7261 (2009): 272-6.
description	12.	Sherr, Charles J J. "Principles of tumor suppression." Cell 116.2 (2003): 235-46.
description	13.	Filipowicz, W. "Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?" Nature reviews. Genetics 9.2 (2008): 102-14.
description	14.	Melmed, S. "Pituitary-Tumor Endocrinopathies." The New England journal of medicine. 382.10: 937-950.
description	15.	Zhang, H. "HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases." Breast cancer research and treatment 134.2 (2012): 743-7.
description	16.	Madhusudan, S. "A Multicenter phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene." Clinical cancer research 10.9 (2004): 2986-2996.
description	17.	Carney, W. "Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy." Cancer 104.2 (2005): 257-263.
description	18.	Wass, John A H A. "Silent corticotroph adenomas." Arquivos brasileiros de endocrinologia e metabologia 51.8 (2007): 1314-8.
description	19.	Uchida, K. "Renal transplantation and secondary hyperparathyroidism." Seminars in surgical oncology 13.2 (1997): 97-103.
description	20.	Hicks, D. "Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines." Human Pathology 36.3 (2005): 250-261.